BioSynthesis of Pharmaceuticals via Technologies

Our core technology is a novel technique for the assembly of DNA units. Traditional approaches to assembly can be extremely complex and limited by the availability of unique restriction enzymes. As the number of units to be joined increases, this problem becomes a serious impediment.

technology circumvents this difficulty by means of the Protectable Junction Construct™, ingeniously protecting junctions as they are made, allowing for the sequential addition of DNA fragments to a growing DNA construct . Our elegant technology reduces the addition of a DNA unit to a set of predefined steps, making assembly a simple repetetive process.

The easy assembly of a DNA sequence of arbitrary length from desired starting units is an attractive prospect. Consider that DNA thus constructed can be inserted into a suitable host, which will make a bioactive molecule based on the DNA supplied. 's technology provides excellent control over the DNA so constructed, permitting the biosynthesis of active biomolecules with a power and precision that cannot be achieved by other DNA manipulating techniques.

technology therefore has enormous potential for application in the pharmaceutical arena.

Novel BioSynthesis of Pharmaceuticals

Core Technology: The Assembly of DNA Units

Please contact us if you are interested in using these technologies.